Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Examination of the genetic mechanisms underlying the thalassaemias has led to a clearer understanding of the control of eukaryotic genes in general. Inherited disorders of haemoglobin synthesis are an important cause worldwide of morbidity and mortality, and place a large burden on patients, families, and ultimately communities. The haemoglobin disorders can be controlled, by counselling and prenatal diagnosis. Treatment is usually symptomatic, though bone-marrow transplantation for beta-thalassaemia may be successful in suitable patients.

Original publication

DOI

10.1016/s0140-6736(00)02073-0

Type

Journal article

Journal

Lancet

Publication Date

01/04/2000

Volume

355

Pages

1169 - 1175

Keywords

Erythrocyte Membrane, Erythrocytes, Erythropoiesis, Hemoglobinopathies, Hemoglobins, Humans, Thalassemia